UNION OF INDIA vs M/S. RANBAXY LABORATORIES LTD. .

The Supreme Court addressed the regulatory framework under the Drugs (Price Control) Order, 1995, and the Essential Commodities Act, 1955, specifically Section 3. The Court held that manufacturers must adhere to existing notified prices upon the expiration of exemptions granted for bulk drugs, emphasizing compliance with the guidelines issued by the Central Government. The judgment clarified that failure to comply with these provisions could result in recovery actions under the relevant statutory framework.